ISID Knowledge Exchange Live Webinar: Chikungunya Vaccines Development

Save the date for our next live, open-access webinar, Chikungunya Vaccines Development, happening on September 26, 2023 at 8am EST/ 12pm GMT/ 2pm CET.

Add to Google Calendar
Add to Apple Calendar
Add to Outlook Calendar

Chikungunya virus (CHIKV) has been identified as a priority pathogen and as an emerging infectious disease requiring special action by the World Health Organization (WHO). Its re-emergence is rapid and geographically extensive, it has caused large outbreaks with high attack rates in Africa, Asia, Europe, the Americas, and islands in the Indian and Pacific Oceans. Although Chikungunya fever is a self-limiting disease and the associated fatality rate is low, Chikungunya-related death has been reported in certain populations, especially in people with pre-existing conditions.

Since there is no specific treatment, there is a medical need for prophylaxis against CHIKV infection. Some promising preclinical and clinical vaccine candidates have been developed during recent years, involving a wide range of technology platforms including inactivated Viruses and Subunit Vaccines, Live-Attenuated Viruses, Virus-Like Particles, Viral Vector Vaccines, and Nucleic Acid-Based Vaccines. Advancing developments in current candidates in the pipeline as well as further R&D work required is crucial as it is understanding the epidemiological gaps and modeling needs to perform further efficacy trials; in this webinar, some of these aspects will be presented and questions welcomed from the audience.

Speaker:

• Diana Rojas Alvarez, Switzerland

Chair: ISID Council Member, Fingani Mphande-Nyasulu, Thailand

*This webinar is supported by an unrestricted educational grant from Valneva.